Evidence map›Paper›PMID 31703299›Full record

ArticleMolecules (Basel, Switzerland)2019

Hybridization of Particulate Methane Monooxygenase by Methanobactin-Modified AuNPs.

Jia-Ying Xin, Li-Rui Sun, Hui-Ying Lin, Shuai Zhang, Chun-Gu Xia

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jia-Ying XinKey Laboratory of Food Science and Engineering, Harbin University of Commerce, Harbin 150076, China.
Li-Rui SunKey Laboratory of Food Science and Engineering, Harbin University of Commerce, Harbin 150076, China.
Hui-Ying LinKey Laboratory of Food Science and Engineering, Harbin University of Commerce, Harbin 150076, China.
Shuai ZhangKey Laboratory of Food Science and Engineering, Harbin University of Commerce, Harbin 150076, China.
Chun-Gu XiaState Key Laboratory of Oxo Synthesis and Selective Oxidation, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
Harbin University of Commerce · CNLanzhou Institute of Chemical Physics · CN

Funding

National Natural Science Foundation of China 21573055Open Project Program of the State Key Laboratory for Oxosynthesis & Selective Oxidation for Support NAprogram of Harbin University of Commerce YJSCX2018-481HSD
6 · The paper itself

Abstract

Particulate methane monooxygenase (pMMO) is a characteristic membrane-bound metalloenzyme of methane-oxidizing bacteria that can catalyze the bioconversion of methane to methanol. However, in order to achieve pMMO-based continuous methane-to-methanol bioconversion, the problems of reducing power in vitro regeneration and pMMO stability need to be overcome. Methanobactin (Mb) is a small copper-chelating molecule that functions not only as electron carrier for pMMO catalysis and pMMO protector against oxygen radicals, but also as an agent for copper acquisition and uptake. In order to improve the activity and stability of pMMO, methanobactin-Cu (Mb-Cu)-modified gold nanoparticle (AuNP)-pMMO nanobiohybrids were straightforwardly synthesized via in situ reduction of HAuCl

Indexed as

Bacterial ProteinsEnzymes, ImmobilizedEnzyme StabilityGoldImidazolesMetal NanoparticlesMethylosinus trichosporiumOligopeptidesOxygenasesBacterial ProteinsEnzymes, ImmobilizedGoldImidazolesmethane monooxygenasemethanobactinOligopeptidesOxygenasesAuNPselectron donorhydroquinonemethanobactinnanobiohybridsparticulate methane monooxygenase

Identifiers

PMID31703299
PMCPMC6891627
OpenAlexW2984042263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.